-
Abstract: Late treatment with alpha GPC for increasesing hippocampal neurogenesis and providing protection against epilepsy seizure-induced neuronal death and cognitive impairment
Jun , 03 2021
Choline alfoscerate (α-GPC; alpha GPC; L-alpha glycerylphosphorylcholine; CAS No.:28319-77-9) is common choline compound and acetycholine precursor in the brain, which has been shown to be effective i...
read more
-
Abstract: Rhodiola rosea: A Possible Plant Adaptogen
Jun , 03 2021
Rhodiola rosea is a popular plant in traditional medical systems in Eastern Europe and Asia with a reputation for stimulating the nervous system, decreasing depression, enhancing work performance, eli...
read more
-
Abstract: Rhodiola rosea L. as a putative botanical antidepressant
Jun , 03 2021
Background: Rhodiola rosea (R. rosea) is a botanical adaptogen with putative anti-stress and antidepressant properties. Evidence-based data supporting the effectiveness of R. rosea for depression in a...
read more
-
Scientific supports for NMN to liberate aging through NAD+
May , 26 2021
β-Nicotinamide mononucleotide (short name: NMN CAS No.: 1094-61-7) is an inherent metabolite of the human body, which can be directly converted into the key coenzyme NAD+(NICOTINAMIDE ADENINE DINUCLEO...
read more
-
NMN news : NMN helps prevent and treat acute kidney injury (AKI)
May , 26 2021
As we all know, whether in developed or developing countries, the incidence and mortality of acute kidney injury (AKI) are increasing year by year. At present, renal replacement therapy (RRT) is one o...
read more
-
NMN has many potentials to help human health
May , 26 2021
In the past 3-4 years, Science, the most prestigious academic journal in the world, has continuously published experiments on the repairing effect of Nicotinamide Mononucleotide （NMN CAS No. : 1094-61...
read more
-
NMN can improve diabetic nephropathy by up-regulating BMP7
May , 26 2021
Diabetic nephropathy is one of the most common chronic complications of diabetes, and its incidence is also on the rise. It has become the second cause of end-stage renal disease, second only to vario...
read more
-
Studies have found that NMN has an effective preventive and therapeutic effect on osteoporosis
May , 08 2021
Osteoporosis is a systemic bone disease in which bone density and bone quality are reduced due to various reasons, bone microstructure is destroyed, and bone fragility is increased, which is prone to ...
read more
-
How much NMN does the human body need to supplement?
May , 07 2021
β-Nicotinamide mononucleotide (short name: NMN, CAS No.: 1094-61-7) is the precursor of NAD ( NICOTINAMIDE ADENINE DINUCLEOTIDE; NAD+; β-NAD, CAS No.: 53-84-9 ). NAD is too large to enter c...
read more
-
Unlock new features of β-Nicotinamide mononucleotide / NMN
Apr , 20 2021
In 2021, with the in-depth development of research, NAD+ supplements (NICOTINAMIDE ADENINE DINUCLEOTIDE; NAD+; β-NAD, CAS No.: 53-84-9) represented by β-Nicotinamide mononucleotide (NMN，CAS No.:...
read more
IPv6 network supported
English
中文
français
Deutsch
русский
español
português
العربية
日本語
한국의
Türkçe
